Binsheng Fu, MD,PhD
Titles
Associate Professor of Surgery
Department of Liver Transplantation and Hepatic Surgery
The Third Affiliated Hospital of the Sun Yat-sen University
Research Interests
Liver transplantation
Liver tumor and carcinogenesis
Liver ischemia/reperfusion injury
Education and experience
MD, Anhui Medical University
PhD, Sun Yat-Sen University
Residency, Anhui Provincial Hospital of Anhui Medical University
Fellowship, Third Affiliated Hospital of Sun Yat-Sen University
Observership, University of Pittsburgh Medical Center (UPMC)
Professional membership
Member of Society of Organ Transplantation of Chinese Medical Doctor Association
Deputy director of the youth committee of biliary tract surgery of Chinese Medical Doctor Association
Secretary of Society of Surgery of Guangdong Province Medical Association
Member of youth committee of Surgery of Guangdong Province Medical Association
Deputy director of the youth committee of Pancreatic Cancer Specialized Committee of Cancer Society of Guangdong Province.
Honors and Awards
Postgraduate scholarship of Sun Yat-sen University (2007)
Outstanding Postgraduate of Guangdong Colleges (2008)
Clinical Research of Liver Transplantation in Severe Hepatitis, First prize of Science and Technology Award, Guangdong province.(2008)
Volunteer of health aid program of Guangdong to Xinjiang(2009)
Honor of advanced individual in the Third Affiliated Hospital of Sun Yat-sen University for the excellent performance in medical work.(2014)
Liver Transplantation for Hepatecullar Carcinoma, the first prize of Science and Technology Award, Guangdong province, China.(2015)
Publications
1. Fu BS, Meng W, Zeng X, Zhao H, Liu W, Zhang T. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma. Biomed Res Int 2017: 4698167.
2. Zhang T, Huang Y, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Zhang B, Zou Y, Li HP, Fu BS. Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma. Oncogenesis 2017, 6: e363.
3. Fu BS , Meng W, Zhao H, Zhang B, Tang H, Zou Y, Yao J, Li HP, Zhang T. GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5. Sci Rep 2016; 6:31963.
4. Fu BS, Yang Y, Li H, Zhang T, Chen GH. Hemophagocytic syndrome: a rare but fatal complication after liver transplantation. Chin Med J, 2013, 126(18):3587-3589..
5. Fu BS, Zhang T, Li H, Yi SH, Wang GS, Xu C, Yang Y, Cai CJ, Lu MQ, Chen GH. The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience. Eur Surg Res, 2011, 47(4): 218-221.
6. Chen GH, Fu BS, Cai CJ, Lu MQ, Yang Y, Yi SH, Xu C, Li H, Wang GS, Zhang T. A Single-Center Experience of Retransplantation for Liver Transplant Recipients with a Failing Graft. Transplant Proc, 2008, 40(5): 1485-1487.
7. Chen GH, Fu BS, Yang Y, Cai CJ, Lu MQ, Li H, Wang GS, Yi SH, Xu C, Zhang JF, Zhang T, Wang GY. Early liver retransplantation versus late liver retransplantation: analysis of a single-center experience. Chin Med J, 2008, 121(20): 1992-1996.
8. Zhang YC, Liu W, Fu BS, Wang GY, Li HB, Yi HM, Jiang N, Wang G, Zhang J, Yi SH, Li H, Zhang Q, Yang Y, Chen GH. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation. Cytotherapy.2017, 19: 194-199.
9. Chen SP, Zhang LS, Fu BS, Zeng XC, Yi HM, Jiang N. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Medicine (Baltimore) 2015;94:e423.
10. Yi SH, Yi HM, Fu BS, Xu C, Li MR, Zhang Q, Yang Y, Chen GH. Long-term results of liver transplantation for over 60 years old patients with hepatitis B virus-related end-stage liver disease. Hepatobiliary Pancreat Dis Int, 2014,13(5):501-7.
11. Li H, He JW, Fu BS, Wang K, Jiang N, Wang GY, Zhang J, Wang GS, Yang Y, Chen GH.Immunosuppressant-related hip pain after orthotopic liver transplant. Exp Clin Transplant. 2013, 11(1):32-38.
12. Yang Y, Li H, Fu BS, Zhang Q, Zhang YC, Lu MQ, Cai CJ, Xu C, Wang GS, Yi SH, Zhang J, Zhang JF, Yi HM, Jiang N, Jiang H, Zhu KS, Jiang ZB, Sha H, Chen GH. Hepatic artery complications after orthotopic liver transplantation: interventional treatment or retransplantation? Chin Med J, 2008, 121(20): 1997-2000.
13. Jia CC, Wang TT, Liu W, Fu BS, Hua X, Wang GY, Li TJ, Li X, Wu XY, Tai Y, Zhou J, Chen GH, Zhang Q. Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion. PLoS One. 2013, 8(5):e63243.
Contact
Office address: 600 TianHe Road, TianHe District or 2693 Kaichuang RD, Guangzhou, P.R., China, 510630
Office Tel: 86(20)-85252276
E-mail: andyfu79@163.com
